Prognostic characterization of immune molecular subtypes in non-small cell lung cancer to immunotherapy
Abstract Background Non-small cell lung cancer (NSCLC) was usually associated with poor prognosis and invalid therapeutical response to immunotherapy due to biological heterogeneity. It is urgent to screen reliable biomarkers, especially immunotherapy-associated biomarkers, that can predict outcomes...
Saved in:
Main Authors: | , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
BMC
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/22ade93edf0944fea407007df5cc0fcb |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|